Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,14S,17S,20S,23S,26S,29S,35S,38S,41S,44S,47S,50S,53S,56S,59S)-29-((1H-imidazol-5-yl)methyl)-44-((1H-indol-3-yl)methyl)-62-amino-41-(3-amino-3-oxopropyl)-38,47-bis(4-aminobutyl)-14-sec-butyl-8,20,50,53-tetrakis(3-guanidinopropyl)-35-((R)-1-hydroxyethyl)-2,59-bis(hydroxymethyl)-5-isobutyl-23-isopropyl-17,26,56-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61-icosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60-icosaazadohexacontan-1-oic acid
ID: ALA3337496
Chembl Id: CHEMBL3337496
PubChem CID: 118714732
Max Phase: Preclinical
Molecular Formula: C100H171N39O26
Molecular Weight: 2335.71
Molecule Type: Protein
Associated Items: